Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S.
Learn MoreFresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S.
Learn MoreThe Annual General Meeting took place on Thursday, 22 May 2025, at 10:00 am (CEST)
Learn More5 Ways Fresenius Medical Care Is Reducing Its Environmental Impact around the World
Learn MoreHealth Equity in Kidney Care: Interview with Lorien Dalrymple, MD, MPH
Learn MoreHealthcare innovation through technology: Augmented Reality, cloud-based data, and more
Learn MorePredicting Population Trends in Kidney Health Using Advanced Mathematical Modeling
Learn More